Catalyst Watch: Spotlight on Tesla, Alphabet earnings, AACR drug data, and global PMI reports
Source: SeekingAlpha
2025-04-18 12:00:35 ET
More on SPDR S&P 500 ETF Trust
- Is The S&P 500 Mispricing Risk Or Hiding Opportunity? The Case For Holding Steady In A Split Market
- A Recessionary Crisis Becomes More And More Likely
- Inflation Expectations Suggest A Further Major Fall In S&P 500
- Is the stock market open on Good Friday?
- Trump cues tit-for-tat China tariffs near end, TikTok deal may have to wait
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Spotlight on Tesla, Alphabet earnings, AACR drug data, and global PMI reports
Autolus Therapeutics plc
NASDAQ: AUTL
AUTL Trading
22.54% G/L:
$1.93 Last:
4,124,476 Volume:
$1.62 Open:
AUTL Latest News
May 14, 2026 07:00:00 am
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business UpdatesMay 05, 2026 07:00:00 am
Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026April 29, 2026 04:05:00 pm
Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost ReductionAUTL Stock Data
$387,238,481
109,839,996
N/A
49
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
